TÜV SÜD Product Service has issued their first In Vitro Medical Device Regulation (IVDR) certificate since receiving notification in June 2020 – and the first IVDR certificate worldwide. The IVDR, which came into force in May 2017, must be implemented by late May 2022.

 BIVDA Chief Executive Doris-Ann Williams has welcomed the confirmation of the first COVID-19 vaccine to be approved by British regulators. Doris-Ann said; “We are delighted that the MHRA have approved the Pfizer/BioNTech coronavirus vaccine for widespread use, meaning it can start its roll out from next week. On behalf of BIVDA and the in vitro diagnostics sector, I would like to congratulate all those involved in this incredible scientific achievement.  An effective v...

Controlled Drug Denature Kits

BIVDA Chief Executive Doris-Ann Williams has commented on the launch of the Medicines and Diagnostic Manufacturing Transformation Fund. “We welcome the announcement of the Medicines and Diagnostic Manufacturing Transformation Fund by the Prime Minister today.  The lessons the country has learned during this difficult year in pandemic response must not be forgotten, and the innovations should be used to improve our diagnostic testing system for non-COVID illnesses including cancer...

BIVDA Comments on Spending Review 2020 BIVDA has commented on Chancellor Rishi Sunak’s speech to the House of Commons, where he announced the results of the 2020 Spending Review. Outlining measures designed to help the NHS maintain services as it recovers from the ongoing pandemic, the Chancellor announced £3 billion for recovery projects, including enhanced diagnostic testing, and greater capital spending to help replace outdated diagnostics equipment in hospitals. The NHS budg...

IMMY sõna Aspergillus Galactomannan Lateral Flow Assay recommended by the European Confederation of Medical Microbiology (ECMM) as a screening device in ventilated patients.

New sample collection kit enables convenient and safe collection, transportation and handling of pathogenic samples including COVID-19 and influenza

New Range of CE Certified Face Visors and Type II Masks with Introductory 10% Savings

Demystify chromogenic testing

New QuickGene Range for DNA & RNA Extraction- Now with Automated Option